··6 min read
A new artificial intelligence system is capable of surpassing human experts in breast cancer prediction. The system provided absolute reductions of up to 5.7% in false-positive diagnoses and up to 9.4% in false-negative predictions of the disease.
Combining medications used to treat neurological disorders, such as epilepsy and migraines, with blood pressure medications reversed some aspects of breast cancer in mice at high risk of developing the disease due to the high-fat diets fed to their mothers during pregnancy.
Researchers say parabens and other chemicals found in common cosmetic products may negatively impact a woman's hormone levels, increasing the risk for certain diseases.
A new study reveals marijuana may be present in breast milk six days after exposure. Researchers report 63% of samples taken from mothers who used cannabis contained traces of THC up to six days after using the drug.
Researchers have found an association between the Per2 gene and breast cancer. The Per2 gene plays an important role in both the body's circadian clock and mammary gland development.
A compound used to treat leukemia shows promise in preventing breast cancer cells from metastasizing in the brain.
A new study reports inflammation in the blood may play a role in cognitive problems following chemotherapy. Researchers report identifying the inflammatory biomarkers and reducing inflammation may prevent some of the symptoms of chemo brain.
Many breast cancer survivors report cognitive problems following treatment. New research from UCSD finds breast cancer survivors who increase physical activity and embark on regular exercise experience improved mental processing.
Scientist reveal a drug regiment consisting of anti-inflammatories and anti-stress medications given before and after surgery could reduce cancer recurrence.
Researchers have identified a specific group of circulating tumor cells in the blood stream of patients with breast cancer brain metastases. The finding is helping researchers to develop a new blood test to identify breast cancer patients at risk of developing brain metastasis.